• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

深度学习可对溃疡性结肠炎患者的 Mayo 内镜评分进行分类。

Deep learning enabled classification of Mayo endoscopic subscore in patients with ulcerative colitis.

机构信息

Stanford University School of Medicine, Stanford, California, USA.

出版信息

Eur J Gastroenterol Hepatol. 2021 May 1;33(5):645-649. doi: 10.1097/MEG.0000000000001952.

DOI:10.1097/MEG.0000000000001952
PMID:33079775
Abstract

OBJECTIVE

Previous reports of deep learning-assisted assessment of Mayo endoscopic subscore (MES) in ulcerative colitis have only explored the ability to distinguish disease remission (MES 0/1) from severe disease (MES 2/3) or inactive disease (MES 0) from active disease (MES 1-3). We sought to explore the utility of deep learning models in the automated grading of each individual MES in ulcerative colitis.

METHODS

In this retrospective study, a total of 777 representative still images of endoscopies from 777 patients with clinically active ulcerative colitis were graded using the MES by two physicians. Each image was assigned an MES of 1, 2, or 3. A 101-layer convolutional neural network model was trained and validated on 90% of the data, while 10% was left for a holdout test set. Model discrimination was assessed by calculating the area under the curve (AUC) of a receiver operating characteristic as well as standard measures of accuracy, specificity, sensitivity, positive predictive value (PPV), and negative predictive value (NPV).

RESULTS

In the holdout test set, the final model classified MES 3 disease with an AUC of 0.96, MES 2 disease with an AUC of 0.86, and MES 1 disease with an AUC 0.89. Overall accuracy was 77.2%. Across MES 1, 2, and 3, average specificity was 85.7%, average sensitivity was 72.4%, average PPV was 77.7%, and the average NPV was 87.0%.

CONCLUSION

We have demonstrated a deep learning model was able to robustly classify individual grades of endoscopic disease severity among patients with ulcerative colitis.

摘要

目的

先前关于深度学习辅助评估溃疡性结肠炎 Mayo 内镜评分(MES)的报告仅探索了区分疾病缓解(MES0/1)与严重疾病(MES2/3)或非活动疾病(MES0)与活动疾病(MES1-3)的能力。我们旨在探索深度学习模型在溃疡性结肠炎中自动分级每个个体 MES 的效用。

方法

在这项回顾性研究中,两名医生使用 MES 对 777 例临床活动性溃疡性结肠炎患者的 777 个代表性内镜静止图像进行了分级。每张图像均被分配了 1、2 或 3 的 MES。在 90%的数据上训练和验证了一个 101 层卷积神经网络模型,而 10%的数据则保留用于验证测试集。通过计算受试者工作特征曲线下的面积(AUC)以及准确性、特异性、敏感性、阳性预测值(PPV)和阴性预测值(NPV)的标准衡量标准来评估模型的区分度。

结果

在验证测试集中,最终模型对 MES3 疾病的分类 AUC 为 0.96,对 MES2 疾病的分类 AUC 为 0.86,对 MES1 疾病的分类 AUC 为 0.89。整体准确率为 77.2%。在 MES1、2 和 3 中,平均特异性为 85.7%,平均敏感性为 72.4%,平均 PPV 为 77.7%,平均 NPV 为 87.0%。

结论

我们已经证明,深度学习模型能够稳健地对溃疡性结肠炎患者的内镜疾病严重程度进行个体分级。

相似文献

1
Deep learning enabled classification of Mayo endoscopic subscore in patients with ulcerative colitis.深度学习可对溃疡性结肠炎患者的 Mayo 内镜评分进行分类。
Eur J Gastroenterol Hepatol. 2021 May 1;33(5):645-649. doi: 10.1097/MEG.0000000000001952.
2
Performance of a Deep Learning Model vs Human Reviewers in Grading Endoscopic Disease Severity of Patients With Ulcerative Colitis.深度学习模型与人类评估者在溃疡性结肠炎患者内镜疾病严重程度分级中的表现比较。
JAMA Netw Open. 2019 May 3;2(5):e193963. doi: 10.1001/jamanetworkopen.2019.3963.
3
Deep learning model for distinguishing Mayo endoscopic subscore 0 and 1 in patients with ulcerative colitis.用于区分溃疡性结肠炎患者 Mayo 内镜评分 0 与 1 的深度学习模型。
Sci Rep. 2023 Jul 13;13(1):11351. doi: 10.1038/s41598-023-38206-6.
4
Application of deep learning in the diagnosis and evaluation of ulcerative colitis disease severity.深度学习在溃疡性结肠炎疾病严重程度诊断与评估中的应用
Therap Adv Gastroenterol. 2023 Dec 22;16:17562848231215579. doi: 10.1177/17562848231215579. eCollection 2023.
5
Prognosis of ulcerative colitis differs between patients with complete and partial mucosal healing, which can be predicted from the platelet count.溃疡性结肠炎患者的预后在黏膜完全愈合和部分愈合的患者之间有所不同,这可以通过血小板计数来预测。
World J Gastroenterol. 2014 Dec 28;20(48):18367-74. doi: 10.3748/wjg.v20.i48.18367.
6
Role of Ulcerative Colitis Endoscopic Index of Severity (UCEIS) versus Mayo Endoscopic Subscore (MES) in Predicting Patients' Response to Biological Therapy and the Need for Colectomy.溃疡性结肠炎内镜严重指数(UCEIS)与 Mayo 内镜亚评分(MES)在预测生物治疗患者反应和结肠切除需求中的作用。
Digestion. 2021;102(4):534-545. doi: 10.1159/000509512. Epub 2020 Jul 31.
7
Assessment of disease activity by fecal immunochemical test in ulcerative colitis.通过粪便免疫化学检测评估溃疡性结肠炎的疾病活动度。
World J Gastroenterol. 2016 Dec 28;22(48):10617-10624. doi: 10.3748/wjg.v22.i48.10617.
8
Clinical value of the Toronto inflammatory bowel disease global endoscopic reporting score in ulcerative colitis.多伦多炎症性肠病全球内镜报告评分在溃疡性结肠炎中的临床价值。
World J Gastroenterol. 2023 Dec 28;29(48):6208-6221. doi: 10.3748/wjg.v29.i48.6208.
9
High Accuracy in Classifying Endoscopic Severity in Ulcerative Colitis Using Convolutional Neural Network.使用卷积神经网络实现溃疡性结肠炎内镜严重程度的高精度分类。
Am J Gastroenterol. 2022 Oct 1;117(10):1648-1654. doi: 10.14309/ajg.0000000000001904. Epub 2022 Jul 15.
10
Fecal calprotectin predicts complete mucosal healing and better correlates with the ulcerative colitis endoscopic index of severity than with the Mayo endoscopic subscore in patients with ulcerative colitis.粪便钙卫蛋白可预测溃疡性结肠炎患者的黏膜完全愈合,且与溃疡性结肠炎内镜严重程度指数的相关性优于与梅奥内镜亚评分的相关性。
BMC Gastroenterol. 2017 Oct 23;17(1):110. doi: 10.1186/s12876-017-0669-7.

引用本文的文献

1
Asia Pacific association of gastroenterology consensus statements on histopathological evaluation of inflammatory bowel diseases.亚太胃肠病学协会关于炎症性肠病组织病理学评估的共识声明
Therap Adv Gastroenterol. 2025 Aug 19;18:17562848251363703. doi: 10.1177/17562848251363703. eCollection 2025.
2
Digital biomarkers and artificial intelligence: a new frontier in personalized management of inflammatory bowel disease.数字生物标志物与人工智能:炎症性肠病个性化管理的新前沿。
Front Immunol. 2025 Aug 4;16:1637159. doi: 10.3389/fimmu.2025.1637159. eCollection 2025.
3
Artificial Intelligence in Inflammatory Bowel Disease Endoscopy.
炎症性肠病内镜检查中的人工智能
Diagnostics (Basel). 2025 Apr 1;15(7):905. doi: 10.3390/diagnostics15070905.
4
Ulcerative Colitis, LAIR1 and TOX2 Expression, and Colorectal Cancer Deep Learning Image Classification Using Convolutional Neural Networks.溃疡性结肠炎、LAIR1和TOX2表达以及使用卷积神经网络的结直肠癌深度学习图像分类
Cancers (Basel). 2024 Dec 19;16(24):4230. doi: 10.3390/cancers16244230.
5
Artificial Intelligence in Coloproctology: A Review of Emerging Technologies and Clinical Applications.结直肠外科学中的人工智能:新兴技术与临床应用综述
J Clin Med. 2024 Sep 30;13(19):5842. doi: 10.3390/jcm13195842.
6
How Artificial Intelligence Will Transform Clinical Care, Research, and Trials for Inflammatory Bowel Disease.人工智能将如何改变炎症性肠病的临床护理、研究和试验。
Clin Gastroenterol Hepatol. 2025 Feb;23(3):428-439.e4. doi: 10.1016/j.cgh.2024.05.048. Epub 2024 Jul 9.
7
The Role of Artificial Intelligence in the Diagnosis and Treatment of Ulcerative Colitis.人工智能在溃疡性结肠炎诊断与治疗中的作用。
Diagnostics (Basel). 2024 May 13;14(10):1004. doi: 10.3390/diagnostics14101004.
8
Artificial intelligence in endoscopy related to inflammatory bowel disease: A systematic review.与炎症性肠病相关的内镜检查中的人工智能:一项系统综述。
Indian J Gastroenterol. 2024 Feb;43(1):172-187. doi: 10.1007/s12664-024-01531-3. Epub 2024 Feb 28.
9
Impact of artificial intelligence on prognosis, shared decision-making, and precision medicine for patients with inflammatory bowel disease: a perspective and expert opinion.人工智能对炎症性肠病患者预后、共同决策和精准医学的影响:观点和专家意见。
Ann Med. 2023;55(2):2300670. doi: 10.1080/07853890.2023.2300670. Epub 2024 Jan 1.
10
Using a Deep Learning Model to Address Interobserver Variability in the Evaluation of Ulcerative Colitis (UC) Severity.使用深度学习模型解决溃疡性结肠炎(UC)严重程度评估中的观察者间差异。
J Pers Med. 2023 Nov 8;13(11):1584. doi: 10.3390/jpm13111584.